Skip to main navigation Skip to search Skip to main content

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

Translated title of the contribution: Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
  • G. Fatkenheuer
  • , A.L. Pozniak
  • , M.A. Johnson
  • , A. Plettenberg
  • , S. Staszewski
  • , I.M. Hoepelman
  • , M.S. Saag
  • , F.D. Goebel
  • , J.K. Rockstroh
  • , B.J. Dezube
  • , T.M. Jenkins
  • , C. Medhurst
  • , J.F. Sullivan
  • , C. Ridgway
  • , S.A. Abel
  • , I.T. James
  • , M. Youle
  • , E. van der Ryst

Research output: Contribution to journalArticleAcademic

Translated title of the contributionEfficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Original languageUndefined/Unknown
Pages (from-to)1170-1172
Number of pages3
JournalNature Methods
Volume11
Issue number11
Publication statusPublished - 2005

Cite this